Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
205.00
-7.11 (-3.35%)
Oct 3, 2024, 4:00 PM EDT - Market closed
Inspire Medical Systems Revenue
Inspire Medical Systems had revenue of $195.89M in the quarter ending June 30, 2024, with 29.65% growth. This brings the company's revenue in the last twelve months to $705.71M, up 34.14% year-over-year. In the year 2023, Inspire Medical Systems had annual revenue of $624.80M with 53.19% growth.
Revenue (ttm)
$705.71M
Revenue Growth
+34.14%
P/S Ratio
8.88
Revenue / Employee
$698,027
Employees
1,011
Market Cap
6.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 624.80M | 216.94M | 53.19% |
| Dec 31, 2022 | 407.86M | 174.46M | 74.75% |
| Dec 31, 2021 | 233.39M | 118.01M | 102.28% |
| Dec 31, 2020 | 115.38M | 33.33M | 40.62% |
| Dec 31, 2019 | 82.05M | 31.46M | 62.18% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Jun 30, 2013 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.30B |
| Bausch + Lomb | 4.50B |
| Jazz Pharmaceuticals | 3.91B |
| PACS Group | 3.56B |
| Acadia Healthcare Company | 3.06B |
| R1 RCM | 2.38B |
| Ionis Pharmaceuticals | 813.46M |
| Glaukos | 341.73M |
INSP News
- 27 days ago - Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 - PRNewsWire
- 4 weeks ago - Inspire Medical Systems: Inspired, With Improving Risk-Reward (Rating Upgrade) - Seeking Alpha
- 6 weeks ago - Inspire Medical Systems, Inc. to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Inspire Medical Systems, Inc. (INSP) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program - GlobeNewsWire
- 2 months ago - Inspire Medical Systems, Inc. Announces Second Quarter 2024 Financial Results and Updates 2024 Outlook - GlobeNewsWire
- 2 months ago - Inspire Medical Systems, Inc. Announces FDA Approval of the Inspire V System - GlobeNewsWire
- 2 months ago - Sleep Apnea Device Marker Inspire's Stock Rises on Improved Outlook - Investopedia